Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Current standards of treatment in ms and the role of oral agents.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Sunlight and Vitamin D: Necessary for Public Health.
Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: Unexpected Diagnosis After Ultrasound Imaging for a Humeral Fracture.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis: A Role in Immune Cells and Vascular Cells of the Blood-Brain Barrier.
Mean Contact Quotient Using Electroglottography in Patients With Multiple Sclerosis.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Fingolimod and multiple sclerosis: Four cautionary tales.
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Quality of life and employment in persons with multiple sclerosis.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Pages
« first
‹ previous
…
351
352
353
354
355
356
357
358
359
…
next ›
last »